Therapy of hot flushes
Showing 9976 - 10000 of >10,000
Hepatitis D Trial in Athens (Bulevirtide)
Recruiting
- Hepatitis D
-
Athens, GreeceDepartment of Gastroenterology, Medical School of National & Kap
Jun 28, 2023
Hidradenitis Suppurativa Trial in Detroit (Laight therapy, NICE V3.1 device)
Completed
- Hidradenitis Suppurativa
- Laight therapy, NICE V3.1 device
-
Detroit, MichiganHenry Ford Hospital Systems- New Center One
Jun 28, 2023
Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome Trial in Anchorage, Shreveport, Boston (Nitric
Active, not recruiting
- Coronavirus Infections
- +2 more
- Nitric Oxide
-
Anchorage, Alaska
- +2 more
Oct 31, 2022
Type 1 Diabetes, Autoimmune Diabetes Trial in Changsha (Berberine, Inulin, Berberine tablets)
Not yet recruiting
- Type 1 Diabetes Mellitus
- Autoimmune Diabetes
- Berberine
- +3 more
-
Changsha, Hunan, ChinaInstitute of Metabolism and Endocrinology, Second Xiangya Hospit
Feb 8, 2022
Colorectal Cancer, Circulating Tumor DNA, Adjuvant Chemo Trial in Denmark (Capox (or FOLFOX) including flouropyrimidine and
Recruiting
- Colorectal Cancer
- +3 more
- Capox (or FOLFOX) including flouropyrimidine and oxaliplatin combination chemotherapy
- Intensified Follow-up Schedule
-
Aalborg, Denmark
- +3 more
Feb 24, 2022
COVID-19 Trial in Makassar (Eucalyptus Oil, Standard COVID medication)
Completed
- COVID-19
- Eucalyptus Oil
- Standard COVID medication
-
Makassar, South Sulawesi, IndonesiaHasanuddin University Hospital
May 31, 2022
Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore
Recruiting
- Small Cell Neuroendocrine Carcinoma of Bladder
- +2 more
- Atezolizumab
- +4 more
-
Washington, District of Columbia
- +1 more
Jun 27, 2022
Glioblastoma Trial in Phoenix, Jacksonville, Rochester (BI 907828)
Recruiting
- Glioblastoma
- BI 907828
-
Phoenix, Arizona
- +2 more
Jan 9, 2023
Solid Tumor, Gastrointestinal Cancer, Breast Cancer Trial in Singapore (QPOP, CURATE.AI, Azacitidine + docetaxel)
Not yet recruiting
- Solid Tumor
- +2 more
- QPOP
- +4 more
-
Singapore, SingaporeNational University Hospital
May 18, 2022
Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC
Enrolling by invitation
- Primary Biliary Cholangitis
- Obeticholic Acid 5 MG
- +2 more
-
San Diego, CaliforniaIntercept Pharmaceuticals, Inc
Dec 15, 2022
Colitis, Ulcerative Trial in Worldwide (BMS-986165, Placebo Comparator)
Recruiting
- Colitis, Ulcerative
- BMS-986165
- Placebo Comparator
-
San Diego, California
- +25 more
Dec 15, 2022
Clinical Significance of Occult Central Nervous System
Recruiting
- Acute Lymphoblastic Leukemia
- cerebrospinal fluids exams
-
Roma, RM, ItalyTor Vergata University
Mar 17, 2023
Evidence Determining Individualized Cancer Therapy for Incurable
Terminated
- Hematologic Cancer
- Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
-
La Jolla, CaliforniaUCSD Moore's Cancer Center
Jan 31, 2022
Students Trial in New Taipei City (Empathy experience courses and case-base clinical reasoning, case studies)
Not yet recruiting
- Students
- Empathy experience courses and case-base clinical reasoning
- case studies
-
New Taipei City, TaiwanTaipei Medical University Shuang Ho Hospital
Jul 28, 2022
Unresectable Hepatocellular Carcinoma Trial in Boston (Atezolizumab, Bevacizumab, Stereotactic body radiation therapy (SBRT))
Not yet recruiting
- Unresectable Hepatocellular Carcinoma
- Atezolizumab
- +2 more
-
Boston, Massachusetts
- +2 more
Oct 26, 2021
Covid-19, Cognitive Impairment Trial in Birmingham (Speed of Processing Training, Instrumental Activities of Daily Living
Recruiting
- Covid-19
- Cognitive Impairment
- Speed of Processing Training
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 30, 2021
Satisfaction of HIV-infected Patients Treated With
Not yet recruiting
- HIV Infections
- satisfaction survey
- (no location specified)
Jan 16, 2023
Hypercholesterolemia Trial (MK0653, ezetimibe / Duration of Treatment: 4 Weeks)
Completed
- Hypercholesterolemia
- MK0653, ezetimibe / Duration of Treatment: 4 Weeks
- (no location specified)
Feb 7, 2022
Heterotopic Ossification, Humeral Fractures, Radiation Therapy Trial in Louisville (Radiation)
Terminated
- Heterotopic Ossification
- +2 more
- Radiation
-
Louisville, Kentucky
- +1 more
Jan 25, 2022
Advanced/Metastatic Solid Tumors Trial in Huntersville, San Antonio (ADG116)
Recruiting
- Advanced/Metastatic Solid Tumors
-
Huntersville, North Carolina
- +1 more
Mar 23, 2022
Young Children With Motor Disabilities Trial in Taoyuan City (Ride-On Car Training in a standing posture with a 2-hour session,
Not yet recruiting
- Young Children With Motor Disabilities
- Ride-On Car Training in a standing posture with a 2-hour session
- +2 more
-
Taoyuan City, Taoyuan County, Taiwan
- +1 more
Aug 17, 2023
Intervention on Foot and Ankle Function
Recruiting
- Neoplasms
- +2 more
- Physical therapy
-
Minneapolis, MinnesotaChildren's Minnesota
Mar 9, 2022
Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)
Recruiting
- Solid Tumor
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Sep 23, 2022
Radiofrequency Ablation and Cement Augmentation for Treatment of
Recruiting
- Metastatic Malignant Neoplasm in the Spine
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Cerebral Palsy Trial in Chicago, Edmonton, Toronto (Lokomat (LOK), Gait focused physical therapy (fPT), LOK + fPT)
Recruiting
- Cerebral Palsy
- Lokomat (LOK)
- +2 more
-
Chicago, Illinois
- +2 more
Mar 7, 2022